Accéder au contenu
MilliporeSigma

[Vasobral in the treatment of brain lesions: views of physicians and patients].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2013-03-27)
P R Kamchatnov
RÉSUMÉ

A study was based on the survey of 419 neurologists and 1189 their patients with different forms of cerebrovascular diseases using a specially developed questionnaire. In most cases, vasobral was used as a monotherapy or in a complex treatment. Twenty-two percent of physicians reported that vasobral was the most effective compared to other drugs. The good tolerability of treatment (18%) and the broad spectrum of indications and clinical effects (17%) were reported as well. The large percentage (75%) of patients indicated the positive effect of vasobral on memory, reasoning, vertigo etc The maximal effect was identified in the treatment of mild cognitive impairment caused by chronic brain ischemia and vertebrobasilar insufficiency. Vasobral is recommended for a use in a complex therapy in patients with more severe brain lesions and cognitive deficit.

MATÉRIAUX
Numéro du produit
Marque
Description du produit

Supelco
Caféine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Caféine, powder, ReagentPlus®
Sigma-Aldrich
Caféine, anhydrous, 99%, FCC, FG
Supelco
Schmelzpunktstandard 235-237°C, analytical standard
Supelco
Caféine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Caffeine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Caféine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Caféine, Sigma Reference Standard, vial of 250 mg
Sigma-Aldrich
Caféine, meets USP testing specifications, anhydrous
Supelco
Caffeine solution, analytical standard, 1.0 mg/mL in methanol
Supelco
Caféine, traceable to primary standards (LGC)
Sigma-Aldrich
Caféine, anhydrous, tested according to Ph. Eur.
Caféine, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Caféine, BioXtra
Caféine, European Pharmacopoeia (EP) Reference Standard